Immunotherapy for Accessible Tumors Utilizing Delayed Hypersensitivity Reactions and Separated Components of the Immune System
- 1 May 1976
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 60 (3) , 389-418
- https://doi.org/10.1016/s0025-7125(16)31888-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Selective cytotoxicity of peritoneal leucocytes for neoplastic cellsCellular Immunology, 1973
- Immunologically Specific Activation of Macrophages Armed with the Specific Macrophage Arming Factor (SMAF)Experimental Biology and Medicine, 1973
- Control of Carcinogenesis: A Possible Role for the Activated MacrophageScience, 1972
- Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancerCancer, 1972
- Counteraction of the blocking of cell‐mediated tumor immunity by inoculation of unblocking sera and splenectomy: immunotherapeutic effects on primary polyoma tumors in ratsInternational Journal of Cancer, 1972
- In Vitro Nonimmunologic Destruction of Cells with Abnormal Growth Characteristics by Adjuvant Activated MacrophagesExperimental Biology and Medicine, 1972
- RENDERING MACROPHAGES SPECIFICALLY CYTOTOXIC BY A FACTOR RELEASED FROM IMMUNE LYMPHOID CELLSTransplantation, 1971
- Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasmsInternational Journal of Cancer, 1971
- SERUM-MEDIATED PROTECTION OF NEOPLASTIC CELLS FROM INHIBITION BY LYMPHOCYTES IMMUNE TO THEIR TUMOR-SPECIFIC ANTIGENSProceedings of the National Academy of Sciences, 1969
- Effects of Allergic Contact Dermatitis on Basal Cell EpitheliomasArchives of Dermatology, 1965